Corn was Corteva’s largest product and service line in fiscal 2025, bringing in $7.00B of $17.40B (40%).
| Product and Service | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Corn | $5.96B | $6.45B | $6.50B | $7.00B | |||||
| Herbicides | $4.59B | $4.03B | $3.60B | $3.73B | |||||
| Insecticides | $1.83B | $1.60B | $1.72B | $1.67B | |||||
| Soybean | $1.81B | $1.86B | $1.93B | $1.88B | |||||
| Fungicides | $1.45B | $1.11B | $1.08B | $1.14B | |||||
| Other | $1.04B | $978.00M | $961.00M | $819.00M | |||||
| Other Oilseeds | $714.00M | $708.00M | $653.00M | $644.00M | |||||
| Biologicals | $63.00M | $491.00M | $476.00M | $519.00M | |||||
| Total | $17.46B | $17.23B | $16.91B | $17.40B |
Corteva brought in $17.40B from its eight product and service lines in fiscal 2025, the year ended December 31, 2025. That was up 2.9% from $16.91B in fiscal 2024. Corn was the largest at $7.00B (40.2%), ahead of Herbicides at $3.73B (21.4%) and Soybean at $1.88B (10.8%). The other five lines brought in $4.79B combined.
Compared with fiscal 2024, Biologicals grew fastest, up 9.0% to $519.00M, while Other fell the most, down 14.8% to $819.00M. From fiscal 2022 to 2025, combined revenue from these lines fell from $17.46B to $17.40B, a compound annual decline of 0.1%. Corn's share of the total rose from 34.1% to 40.2%.
United States was Corteva’s largest region in fiscal 2025, bringing in $8.27B of $17.40B (48%).
| Geography | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|
| United States | $7.55B | $7.78B | $7.87B | $8.27B | |||||
| Latin America | $4.45B | $3.91B | $3.78B | $3.93B | |||||
| Emea | $3.26B | $3.37B | $3.12B | $3.11B | |||||
| Asia Pacific | $1.46B | $1.36B | $1.35B | $1.34B | |||||
| Canada | $741.00M | $807.00M | $794.00M | $755.00M | |||||
| Total | $17.46B | $17.23B | $16.91B | $17.40B |
Corteva brought in $17.40B from its five regions in fiscal 2025, the year ended December 31, 2025. That was up 2.9% from $16.91B in fiscal 2024. United States was the largest at $8.27B (47.5%), ahead of Latin America at $3.93B (22.6%) and Emea at $3.11B (17.9%). The other two regions brought in $2.09B combined.
Compared with fiscal 2024, United States grew fastest, up 5.1% to $8.27B, while Canada fell the most, down 4.9% to $755.00M. From fiscal 2022 to 2025, combined revenue from these regions fell from $17.46B to $17.40B, a compound annual decline of 0.1%. United States' share of the total rose from 43.3% to 47.5%.
Seed was Corteva’s largest segment in fiscal 2025, bringing in $9.90B of $17.40B (57%).
| Segment | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Seed | $8.98B | $9.47B | $9.55B | $9.90B | |||||
| Crop Protection | $8.48B | $7.75B | $7.36B | $7.50B | |||||
| Total | $17.46B | $17.23B | $16.91B | $17.40B |
Corteva brought in $17.40B from its two segments in fiscal 2025, the year ended December 31, 2025. That was up 2.9% from $16.91B in fiscal 2024. Seed was the largest at $9.90B (56.9%), ahead of Crop Protection at $7.50B (43.1%).
Compared with fiscal 2024, Seed grew 3.7% to $9.90B and Crop Protection grew 1.9% to $7.50B. From fiscal 2022 to 2025, combined revenue from these segments fell from $17.46B to $17.40B, a compound annual decline of 0.1%. Seed's share of the total rose from 51.4% to 56.9%.
Corteva (CTVA) reports its revenue by product and service, by geography and by segment. In fiscal 2025, Corn was its largest product and service line, bringing in $7.00B (40.2% of the total), followed by Herbicides at $3.73B (21.4%).
Corn was Corteva's largest product and service line in fiscal 2025, bringing in $7.00B, or 40.2% of the $17.40B total across its eight product and service lines.
United States was Corteva's largest region in fiscal 2025, bringing in $8.27B, or 47.5% of the $17.40B total across its five regions.
Seed was Corteva's largest segment in fiscal 2025, bringing in $9.90B, or 56.9% of the $17.40B total across its two segments.
Among Corteva's product and service lines that make up at least 2% of revenue, Biologicals grew fastest in fiscal 2025, up 9.0% from $476.00M to $519.00M.
Every figure comes from Corteva's annual financial filings, as reported. Each line keeps the name Corteva gives it, and years follow its fiscal calendar.
Corteva's revenue by product and service goes back to fiscal 2017, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.